Covenance is your committed Contract Development and Manufacturing (CDMO) partner for supporting drug development programs. With over 260 scientists engaged in API and Formulations development and a network of 13 manufacturing sites, Covenance is very well positioned to help progress your late stage clinical candidates as well as provide sustainability to your late life cycle products.
With a flexible asset base and capabilities ranging from development, scale-up and commercialization of APIs and formulations, flexibility is an integral aspect of our services
